Ledger.Open graph →
SEC Form D · filed March 13, 2023

Unicycive Therapeutics, Inc

Offering
$30.2M
Sold
$30.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LOS ALTOS, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

John Townsend · Los Altos, CAExecSandeep Laumas · Los Altos, CADirectorGaurav Aggarwal · Los Altos, CADirectorShalabh Gupta · Los Altos, CAExec · DirectorJohn Ryan · Los Altos, CADirectorMatthew Brennan · Dallas, TXDirectorJake Bender · Dallas, TXExec · DirectorKristen Yarbou · Dallas, TXExecPaul Palmieri · MOUNT WASHINGTON, MDDirectorCraig Mcneil · Dallas, TXDirectorBrigitte Schiller · Los Altos, CADirectorWill Chance · Arlington, VADirectorJoshua Sorin · Vancouver, British Columbia, CanadaExecShane Madden · Vancouver, British Columbia, CanadaDirectorJoseph Palumbo · Vancouver, British Columbia, CanadaExec · DirectorJordan Schmidt · Ventura, CADirectorBrigitte Schiller · Los Altos, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗